M&AChina

China blocks SoftBank's purchase of ABB Robotics' China business, ABB says

Published 2 min read
Source
Data graphic: Deal value: $5.375 billion, enterprise value, Oct 8, 2025; Price multiple: 17.2x 2024 EBITDA, MEKAWIRE calc., March

ABB said on Nov 5 that SoftBank Group had informed it that China's foreign-investment security review office prohibited the acquisition of the ABB Robotics business in China, part of the $5.375 billion deal agreed in October 2025.

ABB said the two companies are in close dialogue and working constructively on the transaction. Bloomberg and Reuters reported on Nov 9 that a carve-out of the China business is under discussion; that remains unconfirmed by either company.

ABB said in a statement on Nov 5 that SoftBank Group had told it China's Office of the Working Mechanism for Foreign Investment Security Review had prohibited the acquisition of the ABB Robotics business in China, as reported by The Robot Report and other outlets. The review office sits under the National Development and Reform Commission. ABB added that the two companies are in close dialogue and are working constructively on the transaction. Neither the NDRC nor SoftBank had published a statement at the time of writing, and MEKAWIRE could not open ABB's statement on its own site, so the wording here rests on outlet reports.

A deal that cleared Brussels

SoftBank agreed on Oct 8, 2025 to buy ABB's robotics division for an enterprise value of $5.375 billion, replacing ABB's earlier plan to spin the unit off as a listed company. The European Commission cleared the deal under its simplified procedure on Mar 11, 2026. China's competition review had also passed, according to reports; the block came from the separate foreign-investment security review. At the time of the EU clearance we calculated the price at 17.2 times the division's 2024 EBITDA.

SoftBank and ABB Robotics: timeline
  • Oct 8, 2025
    Step
    SoftBank agrees to buy ABB Robotics for $5.375B EV
    Basis
    ABB and SoftBank releases
  • Mar 11, 2026
    Step
    European Commission clearance
    Basis
    EUR-Lex decision
  • Nov 5, 2026
    Step
    China security review prohibits the China business
    Basis
    ABB statement, reported
  • Nov 9, 2026
    Step
    China carve-out reportedly discussed
    Basis
    Bloomberg and Reuters, unconfirmed

MEKAWIRE timeline from primary documents and labelled reports.

As of Nov 14, 2026

What is being discussed

On Nov 9, Bloomberg and Reuters reported, as relayed by 로봇신문 (irobotnews), that ABB and SoftBank are looking at separating the China robotics business into its own entity with a different ownership structure, or excluding it from the sale. Manufacturing Dive quoted a person describing all options as on the table, including finding another buyer China would approve. None of this is confirmed by the companies.

MEKAWIRE analysis

The block turns ABB Robotics from one asset into two: a China business that must stay out of SoftBank's hands and a rest-of-world business that still can be sold.

The Financial Times reported that the review cited the risk that robot data could be transferred abroad and used to train AI models. If that reading holds, any foreign buyer of a large Chinese robot installed base faces the same test. The counter-argument is that a carve-out is routine and the price can be adjusted. Signals to watch: an ABB ad hoc release with revised terms, a SoftBank statement in its next results, and whether the long-stop date of the agreement is extended.

Good or bad news for the company?

 

Key facts
EU
Cleared Mar 11, 2026
Decision
China's foreign-investment security review prohibited the China part
Deal value
$5.375 billion enterprise value (Oct 8, 2025)
ABB position
Close dialogue, working constructively (Nov 5)
Price multiple
17.2x 2024 EBITDA (MEKAWIRE calc., March)
Carve-out talks
Reported Nov 9 by Bloomberg and Reuters, unconfirmed
Sources
MEKAWIRE Intelligence
  1. 01

    Why it matters

    China's prohibition puts the agreed scope of SoftBank's ABB Robotics acquisition in question despite EU clearance on March 11, 2026. The decision covers the China business; the supplied facts do not establish the outcome for the remaining transaction. Investors need clarity on which operations SoftBank can acquire before assessing the deal's strategic reach.

  2. 02

    Rival analysis

    The regulatory block creates uncertainty around SoftBank's acquisition, but the supplied material identifies no rival bidders or competitor responses. SoftBank also led Skild AI's $1.4 billion Series C in January 2026, showing another robotics-related investment commitment. No integration plans or competitive performance comparisons are supplied.

  3. 03

    Valuation context

    The disclosed $5.375 billion figure is the enterprise value agreed for ABB's robotics division in October 2025, not ABB's or SoftBank's market capitalization. The 17.2x 2024 EBITDA multiple is a MEKAWIRE calculation, not a separately disclosed valuation. No revised price, China business valuation or current market capitalization is supplied, so any carve-out valuation would be speculative.

  4. 04

    Related papers

    No research papers are included in the supplied material. The evidence concerns transaction terms and regulatory decisions, so it does not support conclusions about robotics technology performance.

  5. 05

    Supply-chain implications

    The supplied facts do not identify factories, suppliers, component dependencies or arrangements for serving customers across a potential China carve-out. If the companies confirm a carve-out, disclosures on manufacturing, sourcing and service responsibilities would help establish operational consequences.

  6. 06

    Signals to watch

    Watch for company confirmation of the China carve-out reported by Bloomberg and Reuters on November 9; neither company has confirmed it. Revised transaction scope, consideration and closing terms would provide a firmer basis for assessing value. ABB's November 5 statement establishes continued dialogue, not an agreed restructuring.

  7. 07

    Analyst view

    Treat this as an unresolved change to transaction scope, with potential valuation consequences. EU clearance does not resolve China's prohibition, and constructive dialogue does not establish a viable revised deal. The investment assessment should turn on confirmed terms rather than the reported carve-out discussions.

  8. 08

    Questions you should be asking

    Can ABB and SoftBank agree on a transaction structure that addresses the prohibition on acquiring the China business? If China is excluded, what price adjustment and operating arrangements would apply? Neither answer is provided in the supplied material.